The Latest
This Week in HIV Research: Life in the Integrase Era
Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.
Can Drugs That Cure Hepatitis C Treat COVID-19? Here’s the State of the Research So Far.
An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.
This Week in HIV Research: The Mind Matters
July 23, 2020: Depression and HIV risk mitigation among MSM; a consistent HIV provider is good for CD4 and viral load; spirituality and HIV prevention; HCV treatment access and reinfection risk.
This Week in HIV Research: Links in a Chain
July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?
HIV Clinical Research Highlights From AIDS 2020, the 23rd International AIDS Conference
COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.
Still No Clear Indication That HIV Status Affects COVID-19 Severity
A pair of presentations at AIDS 2020 provides some of the largest studies to date on COVID-19 among people with HIV, but leaves us with many questions about the interplay between the two viruses.
This Week in HIV Research: Do As We Say, Not As We Do
July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.
Body Mass Index Among People With HIV Is Rising Much Faster Than in the General Population
People living with HIV in the U.S. are experiencing increases in body mass index at a rate three times greater than that of the general U.S. population, according to new research presented at AIDS 2020.
This Week in HIV Research: So Many Relative Risks
July 1, 2020: Quantifying bone fracture risks; real-world lipid effects of switching to TAF; pulmonary function impairment in MSM; immunomodulatory drugs and viral load blips.
This Week in HIV Research: Existing Solutions Won't Close the Race Gap
June 18, 2020: Existing evidence-based interventions aren't enough to close HIV's racial gap; transgender patient outcomes in the HIV care continuum; meeting long-term needs of formerly incarcerated people; acute respiratory illness severity and HIV status.